fenofibrate has been researched along with mart-1 antigen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Appay, V; Boddaert, J; Cabral-Piccin, MP; Caputo, A; Clave, E; Dubois, M; Dupré, L; Folcher, V; Frere, JJ; Fusaro, M; Gallerani, E; Gavioli, R; Gostick, E; Llewellyn-Lacey, S; Nicoli, F; Papagno, L; Price, DA; Toubert, A; Vallet, H | 1 |
1 other study(ies) available for fenofibrate and mart-1 antigen
Article | Year |
---|---|
Altered Basal Lipid Metabolism Underlies the Functional Impairment of Naive CD8
Topics: Adult; Aged; Aged, 80 and over; Aging; Apoptosis; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Division; COVID-19; Female; Fenofibrate; Glucose; HLA-A2 Antigen; Humans; Hypolipidemic Agents; Immunocompetence; Influenza, Human; Lipid Metabolism; Lymphocyte Activation; Male; MART-1 Antigen; Middle Aged; Neoplasms; Peptide Fragments; Rosiglitazone; Single-Blind Method; Vaccination; Viral Vaccines; Young Adult | 2022 |